WEST PHARMACEUTICAL SERVICES INC Quarterly Interest Expense in USD from Q1 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
West Pharmaceutical Services Inc quarterly/annual Interest Expense history and growth rate from Q1 2010 to Q1 2024.
  • West Pharmaceutical Services Inc Interest Expense for the quarter ending March 31, 2024 was $1.6M, a 27.3% decline year-over-year.
  • West Pharmaceutical Services Inc Interest Expense for the twelve months ending March 31, 2024 was $8.4M, a 6.33% increase year-over-year.
  • West Pharmaceutical Services Inc annual Interest Expense for 2023 was $9M, a 13.9% increase from 2022.
  • West Pharmaceutical Services Inc annual Interest Expense for 2022 was $7.9M, a 3.66% decline from 2021.
  • West Pharmaceutical Services Inc annual Interest Expense for 2021 was $8.2M, unchanged from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $8.4M $1.6M -$600K -27.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $9M $1.2M -$500K -29.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $9.5M $2.9M +$700K +31.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $8.8M $2.7M +$900K +50% Apr 1, 2023 Jun 30, 2023 10-Q 2023-07-27
Q1 2023 $7.9M $2.2M $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 $7.9M $1.7M -$900K -34.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $8.8M $2.2M +$400K +22.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $8.4M $1.8M -$100K -5.26% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $8.5M $2.2M +$300K +15.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 $8.2M $2.6M +$500K +23.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $7.7M $1.8M -$300K -14.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 $8M $1.9M -$100K -5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 $8.1M $1.9M -$100K -5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $8.2M $2.1M $0 0% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $8.2M $2.1M $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $8.2M $2M $0 0% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $8.2M $2M -$300K -13% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $8.5M $2.1M -$200K -8.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-22
Q3 2019 $8.7M $2.1M +$100K +5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-23
Q2 2019 $8.6M $2M -$200K -9.09% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-24
Q1 2019 $8.8M $2.3M +$400K +21.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-24
Q4 2018 $8.4M $2.3M +$200K +9.52% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 $8.2M $2M +$600K +42.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-29
Q2 2018 $7.6M $2.2M $0 0% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-29
Q1 2018 $7.6M $1.9M -$200K -9.52% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $7.8M $2.1M +$700K +50% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 $7.1M $1.4M -$800K -36.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-30
Q2 2017 $7.9M $2.2M +$200K +10% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 $7.7M $2.1M -$400K -16% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $8.1M $1.4M -$1.5M -51.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $9.6M $2.2M -$1.5M -40.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $11.1M $2M -$1.4M -41.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $12.5M $2.5M -$1.6M -39% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $14.1M $2.9M -$900K -23.7% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 $15M $3.7M -$800K -17.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-31
Q2 2015 $15.8M $3.4M -$800K -19% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 $16.6M $4.1M +$100K +2.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $16.5M $3.8M -$100K -2.56% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $16.6M $4.5M +$100K +2.27% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $16.5M $4.2M +$100K +2.44% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-03
Q1 2014 $16.4M $4M -$600K -13% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $17M $3.9M +$500K +14.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 $16.5M $4.4M $0 0% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-03
Q2 2013 $16.5M $4.1M -$500K -10.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-01
Q1 2013 $17M $4.6M +$300K +6.98% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $16.7M $3.4M -$1M -22.7% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 $17.7M $4.4M -$100K -2.22% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-04
Q2 2012 $17.8M $4.6M $0 0% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-05
Q1 2012 $17.8M $4.3M -$400K -8.51% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-06
Q4 2011 $18.2M $4.4M -$300K -6.38% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-27
Q3 2011 $18.5M $4.5M +$300K +7.14% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-05
Q2 2011 $18.2M $4.6M +$700K +17.9% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-06
Q1 2011 $17.5M $4.7M +$700K +17.5% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q4 2010 $16.8M $4.7M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-27
Q3 2010 $4.2M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 $3.9M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-08
Q1 2010 $4M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.